Correlation Between Lapidoth and Clal Biotechnology

Can any of the company-specific risk be diversified away by investing in both Lapidoth and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lapidoth and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lapidoth and Clal Biotechnology Industries, you can compare the effects of market volatilities on Lapidoth and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lapidoth with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lapidoth and Clal Biotechnology.

Diversification Opportunities for Lapidoth and Clal Biotechnology

-0.58

Correlation Coefficient

Lapidoth  Clal Biotechnology

Excellent diversification

The 3 months correlation between Lapidoth and Clal is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Lapidoth and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Lapidoth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lapidoth are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Lapidoth i.e., Lapidoth and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Lapidoth and Clal Biotechnology

Assuming the 90 days trading horizon Lapidoth is expected to generate 0.87 times more return on investment than Clal Biotechnology. However, Lapidoth is 1.15 times less risky than Clal Biotechnology. It trades about 0.03 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.14 per unit of risk. If you would invest  650,000  in Lapidoth on August 30, 2024 and sell it today you would earn a total of  5,300  from holding Lapidoth or generate 0.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	94.74%
Values	Daily Returns

Lapidoth  vs.  Clal Biotechnology Industries

Lapidoth

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lapidoth are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Lapidoth sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Lapidoth and Clal Biotechnology

The main advantage of trading using opposite Lapidoth and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lapidoth position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.

The idea behind Lapidoth and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.